Cargando…
IRF1 association with tumor immune microenvironment and use as a diagnostic biomarker for colorectal cancer recurrence
Colorectal cancer (CRC) is considered to be one of the most lethal cancer types globally, and its recurrence is a major treatment challenge. Identifying the factors involved when determining the risk of CRC recurrence is required to improve personalized therapy for patients with CRC. Based on the GS...
Autores principales: | Wu, Yanfang, Zhang, Shuju, Yan, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7039159/ https://www.ncbi.nlm.nih.gov/pubmed/32194669 http://dx.doi.org/10.3892/ol.2020.11289 |
Ejemplares similares
-
IRF7 as an Immune-Related Prognostic Biomarker and Associated with Tumor Microenvironment in Low-Grade Glioma
por: Peng, Shijun, et al.
Publicado: (2021) -
Regulatory effects of IRF4 on immune cells in the tumor microenvironment
por: Lu, Jing, et al.
Publicado: (2023) -
Late recurrence of breast cancer is associated with pro-cancerous immune microenvironment in the primary tumor
por: Takeshita, Takashi, et al.
Publicado: (2019) -
SPARCL1 Is a Novel Prognostic Biomarker and Correlates with Tumor Microenvironment in Colorectal Cancer
por: Zhang, Hai-Ping, et al.
Publicado: (2022) -
Gemcitabine-Resistant Biomarkers in Bladder Cancer are Associated with Tumor-Immune Microenvironment
por: Song, Yuxuan, et al.
Publicado: (2022)